Anhedonia

Anhedonia is a diminished ability to experience pleasure, including from previously enjoyable activities like eating. Because GLP-1 medications act on brain reward and dopamine pathways to reduce hedonic (pleasure-driven) eating, some patients report a broader blunting of enjoyment beyond food. This effect is an active area of research, and anyone experiencing persistent low mood, loss of interest, or reduced enjoyment of life should discuss it with their prescriber — it can be a sign to reassess dose or treatment.

Related guides

GLP-1 medications and anxiety: what the evidence shows, and what to watch — Ask whether a GLP-1 helps or hurts anxiety and the honest answer is: both happen, and most people stay stable. Steadier blood sugar, quieter food noise, and weight change calm some people; a minority develop new or worse anxiety, and drug-safety databases show a small reporting signal. It is not a treatment for anxiety. Here's the balanced evidence and, more usefully, what to monitor and when to get help.

Getting mental health support while on a GLP-1: finding a therapist and the challenges to name — Losing weight on a GLP-1 changes more than your body — appetite, self-image, coping habits, and how others treat you can all shift, sometimes faster than your mind catches up. This is a practical guide to the mental-health challenges people commonly face on these medications, the kinds of therapists who can help, and exactly how to find and afford one — plus the crisis resources to keep close.

GLP-1 medications and ADHD: what to know if you have both — ADHD and obesity travel together, so a lot of people on a GLP-1 also have ADHD — and many take a stimulant. There are no trials of GLP-1s as an ADHD treatment, and it shouldn't be used as one. But if you have both, three practical things matter: stacking two appetite suppressants safely, the real ADHD–eating overlap, and the adherence hurdle a weekly injection poses for an ADHD brain. Here's the honest picture.

GLP-1s and a history of disordered eating: what the evidence says about safety — If you have a history of — or are living with — an eating disorder, a medication that suppresses appetite raises real questions. Here's what the early, mixed evidence actually shows about GLP-1 safety, the genuine concerns, and why this is a decision for a treatment team that includes a mental-health professional.

Body-image lag after weight loss vs. body dysmorphia: how to tell the difference — After losing weight on a GLP-1, many people still 'feel' like their old body — the mind lags behind the mirror. That's common and usually eases. Body dysmorphic disorder is different: a persistent, distorted preoccupation with appearance that needs professional care. Here's how to tell them apart, and where to get help.

Anhedonia

Related terms

Related guides